Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-06-22

Clinical Trial Update: Thymol on Netrin-1 on Obese Patients [Phase 2]

View source ↗

Summary

Phase 2 trial update investigating thymol's effect on Netrin-1 in obese patients with inflammatory response.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Thymol on Netrin-1

Snippet

Sponsor: Centro Universitario de Ciencias de la Salud, Mexico | Conditions: Inflammatory Response, Obesity | Phase 2 | Status: UNKNOWN